Subcortical Deep Gray Matter Pathology in Patients with Multiple Sclerosis Is Associated with White Matter Lesion Burden and Atrophy but Not with Cortical Atrophy: A Diffusion Tensor MRI Study

REFERENCES

1. 1.↵
   1. De Stefano N,
   2. Matthews PM,
   3. Filippi M,
   4. et al

   . Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 2003;60:1157–62

   CrossRef
2. 2.↵
   1. Zivadinov R,
   2. Heininen-Brown M,
   3. Schirda CV,
   4. et al

   . Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study. Neuroimage 2012;59:331–39

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Hulst HE,
   2. Geurts JJ

   . Gray matter imaging in multiple sclerosis: what have we learned? BMC Neurol 2011;11:153

   CrossRefPubMed
4. 4.↵
   1. Lucchinetti CF,
   2. Popescu BF,
   3. Bunyan RF,
   4. et al

   . Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 2011;365:2188–97

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Ceccarelli A,
   2. Rocca MA,
   3. Pagani E,
   4. et al

   . A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes. Neuroimage 2008;42:315–22

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Calabrese M,
   2. Rinaldi F,
   3. Mattisi I,
   4. et al

   . The predictive value of gray matter atrophy in clinically isolated syndromes. Neurology 2011;77:257–63

   CrossRef
7. 7.↵
   1. Minagar A,
   2. Barnett MH,
   3. Benedict RH,
   4. et al

   . The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects. Neurology 2013;80:210–19

   CrossRef
8. 8.↵
   1. Fisher E,
   2. Lee JC,
   3. Nakamura K,
   4. et al

   . Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol 2008;64:255–65

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Zivadinov R,
   2. Havrdová E,
   3. Bergsland N,
   4. et al

   . Thalamic atrophy is associated with development of clinically definite multiple sclerosis. Radiology 2013;268:831–41

   CrossRefPubMed
10. 10.↵
    1. Zivadinov R,
    2. Bergsland N,
    3. Dolezal O,
    4. et al

    . Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 years. AJNR Am J Neuroradiol 2013;34:1931–39

    Abstract/FREE Full Text
11. 11.↵
    1. Benedict RH,
    2. Zivadinov R,
    3. Carone DA,
    4. et al

    . Regional lobar atrophy predicts memory impairment in multiple sclerosis. AJNR Am J Neuroradiol 2005;26:1824–31

    Abstract/FREE Full Text
12. 12.↵
    1. Bakshi R,
    2. Benedict RH,
    3. Bermel RA,
    4. et al

    . T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol 2002;59:62–68

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Bendfeldt K,
    2. Blumhagen JO,
    3. Egger H,
    4. et al

    . Spatiotemporal distribution pattern of white matter lesion volumes and their association with regional grey matter volume reductions in relapsing-remitting multiple sclerosis. Hum Brain Mapp 2010;31:1542–55

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Bö L,
    2. Geurts JJ,
    3. van der Valk P,
    4. et al

    . Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Arch Neurol 2007;64:76–80

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Schmierer K,
    2. Wheeler-Kingshott CA,
    3. Boulby PA,
    4. et al

    . Diffusion tensor imaging of post mortem multiple sclerosis brain. Neuroimage 2007;35:467–77

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Filippi M,
    2. Rocca MA

    . MR imaging of multiple sclerosis. Radiology 2011;259:659–81

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Rovaris M,
    2. Gass A,
    3. Bammer R,
    4. et al

    . Diffusion MRI in multiple sclerosis. Neurology 2005;65:1526–32

    CrossRef
18. 18.↵
    1. Raz E,
    2. Cercignani M,
    3. Sbardella E,
    4. et al

    . Clinically isolated syndrome suggestive of multiple sclerosis: voxelwise regional investigation of white and gray matter. Radiology 2010;254:227–34

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Raz E,
    2. Cercignani M,
    3. Sbardella E,
    4. et al

    . Gray- and white-matter changes 1 year after first clinical episode of multiple sclerosis: MR imaging. Radiology 2010;257:448–54

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Benedict RH,
    2. Hulst HE,
    3. Bergsland N,
    4. et al

    . Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients. Mult Scler 2013;19:1478–84

    Abstract/FREE Full Text
21. 21.↵
    1. Mesaros S,
    2. Rocca MA,
    3. Pagani E,
    4. et al

    . Thalamic damage predicts the evolution of primary-progressive multiple sclerosis at 5 years. AJNR Am J Neuroradiol 2011;32:1016–20

    Abstract/FREE Full Text
22. 22.↵
    1. Senda J,
    2. Watanabe H,
    3. Tsuboi T,
    4. et al

    . MRI mean diffusivity detects widespread brain degeneration in multiple sclerosis. J Neurol Sci 2012;319:105–10

    CrossRefPubMed
23. 23.↵
    1. Tovar-Moll F,
    2. Evangelou IE,
    3. Chiu AW,
    4. et al

    . Thalamic involvement and its impact on clinical disability in patients with multiple sclerosis: a diffusion tensor imaging study at 3T. AJNR Am J Neuroradiol 2009;30:1380–86

    Abstract/FREE Full Text
24. 24.↵
    1. Jehna M,
    2. Langkammer C,
    3. Khalil M,
    4. et al

    . An exploratory study on the spatial relationship between regional cortical volume changes and white matter integrity in multiple sclerosis. Brain Connect 2013;3:255–64

    CrossRefPubMed
25. 25.↵
    1. Henry RG,
    2. Shieh M,
    3. Amirbekian B,
    4. et al

    . Connecting white matter injury and thalamic atrophy in clinically isolated syndromes. J Neurol Sci 2009;282:61–66

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Mühlau M,
    2. Buck D,
    3. Forschler A,
    4. et al

    . White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI. Mult Scler 2013;19:1485–92

    Abstract/FREE Full Text
27. 27.↵
    1. Polman CH,
    2. Reingold SC,
    3. Banwell B,
    4. et al

    . Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292–302

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Behrens TE,
    2. Johansen-Berg H,
    3. Woolrich MW,
    4. et al

    . Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat Neurosci 2003;6:750–57

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Behrens TE,
    2. Woolrich MW,
    3. Jenkinson M,
    4. et al

    . Characterization and propagation of uncertainty in diffusion-weighted MR imaging. Magn Reson Med 2003;50:1077–88

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Benjamini Y,
    2. Hochberg Y

    . Controlling the false discovery rate—a practical and powerful approach to multiple testing. J Roy Stat Soc B Met 1995;57:289–300
31. 31.↵
    1. Batista S,
    2. Zivadinov R,
    3. Hoogs M,
    4. et al

    . Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis. J Neurol 2012;259:139–46

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Bozzali M,
    2. Cercignani M,
    3. Sormani MP,
    4. et al

    . Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging. AJNR Am J Neuroradiol 2002;23:985–88

    Abstract/FREE Full Text
33. 33.↵
    1. Liu Y,
    2. Duan Y,
    3. He Y,
    4. et al

    . Whole brain white matter changes revealed by multiple diffusion metrics in multiple sclerosis: a TBSS study. Eur J Radiol 2012;81:2826–32

    CrossRefPubMed
34. 34.↵
    1. Akbar N,
    2. Lobaugh NJ,
    3. O'Connor P,
    4. et al

    . Diffusion tensor imaging abnormalities in cognitively impaired multiple sclerosis patients. Can J Neurol Sci 2010;37:608–14

    PubMed
35. 35.↵
    1. Hasan KM,
    2. Walimuni IS,
    3. Abid H,
    4. et al

    . Human brain atlas-based multimodal MRI analysis of volumetry, diffusimetry, relaxometry and lesion distribution in multiple sclerosis patients and healthy adult controls: implications for understanding the pathogenesis of multiple sclerosis and consolidation of quantitative MRI results in MS. J Neurol Sci 2012;313:99–109

    CrossRefPubMed
36. 36.↵
    1. Yu HJ,
    2. Christodoulou C,
    3. Bhise V,
    4. et al

    . Multiple white matter tract abnormalities underlie cognitive impairment in RRMS. Neuroimage 2012;59:3713–22

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Bozzali M,
    2. Spanò B,
    3. Parker G,
    4. et al

    . Anatomical brain connectivity can assess cognitive dysfunction in multiple sclerosis. Mult Scler 2013;19:1161–68

    Abstract/FREE Full Text
38. 38.↵
    1. Ciccarelli O,
    2. Werring DJ,
    3. Wheeler-Kingshott CA,
    4. et al

    . Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology 2001;56:926–33

    CrossRef
39. 39.↵
    1. Hannoun S,
    2. Durand-Dubief F,
    3. Confavreux C,
    4. et al

    . Diffusion tensor-MRI evidence for extra-axonal neuronal degeneration in caudate and thalamic nuclei of patients with multiple sclerosis. AJNR Am J Neuroradiol 2012;33:1363–68

    Abstract/FREE Full Text
40. 40.↵
    1. Zhao DD,
    2. Zhou HY,
    3. Wu QZ,
    4. et al

    . Diffusion tensor imaging characterization of occult brain damage in relapsing neuromyelitis optica using 3.0T magnetic resonance imaging techniques. Neuroimage 2012;59:3173–77

    CrossRefPubMed
41. 41.↵
    1. Hasan KM,
    2. Walimuni IS,
    3. Abid H,
    4. et al

    . Multimodal quantitative magnetic resonance imaging of thalamic development and aging across the human lifespan: implications to neurodegeneration in multiple sclerosis. J Neurosci 2011;31:16826–32

    Abstract/FREE Full Text
42. 42.↵
    1. Hughes EJ,
    2. Bond J,
    3. Svrckova P,
    4. et al

    . Regional changes in thalamic shape and volume with increasing age. Neuroimage 2012;63:1134–42

    CrossRefPubMedWeb of Science
43. 43.↵
    1. Oreja-Guevara C,
    2. Rovaris M,
    3. Iannucci G,
    4. et al

    . Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study. Arch Neurol 2005;62:578–84

    CrossRefPubMedWeb of Science